Jess:
We announced grants and contracts recently but were not included in this extensive list of biotechs receiving same. Any ideas why?
1)Peregrine marches to a different drummer?
No, PPHM is in the same business as those companies listed.
2) Tustin is waiting for the RS to release any of this information so the post split price doesn't decline too much?
No, PPHM released the info about the grants and contracts,
3)Peregrine isn't as well known as some would have us beleive? Recall all the PS abstracts which some think are related to Bavi and Peregrine yet neither are ever mentioned.
Bingo! Peregrine has no control over which companies are covered by the media and companies trading below $1 do not get the same coverage as those trading above $1. However, BP are mostly very aware of PPHM’s pipeline and are awaiting results of the ongoing clinical trials.
4)I'm sure there are many more reasons.
Maybe, but our “too low” price prevents CNBC, et al, from covering PPHM and prohibits many large and institutional investors from following PPHM. This is why we must get the price up, one way or another.
Market Data 
Markets 
AI
